Diagnostic value of recombinant tuberculosis allergen and Т-spot for the diagnosis of tuberculosis in patients with HIV infection
https://doi.org/10.22328/2077-9828-2025-17-3-83-89
Abstract
The aim of the study. To determine the diagnostic significance of recombinant tuberculosis allergen and T-SPOT for the diagnosis of tuberculosis in patients with HIV infection.
Materials and methods. In 25 patients (72.0% (18/25) male and 28.0% (7/25) female), who had verified tuberculosis in combination with HIV infection, an immunological study was performed using the recombinant tuberculosis allergen and the TSPOT test. The statistical modeling method was simple logistic regression, calculating the likelihood ratio for intervals of the number of CD4 lymphocytes.
Results and discussion. From the CD4 lymphocyte level of 200 cells/ml, the probability curve of a positive test result with the recombinant tuberculosis allergen increases sharply and, starting from the CD4 lymphocyte level of 600 cells/ml (the minimum threshold of a healthy person), takes on a probability close to 1.0 (100%). For the T-SPOT immunological test, the probability curve of a positive test result is more than 50% at a CD4 lymphocyte level of less than 200 cells/mll, approximately 100 cells/mll, and at a CD4 lymphocyte level slightly above 200 cells/ml, the probability curve approaches 1.0 (100%).
Conclusion. In diagnostically difficult cases in a patient with HIV infection, it is preferable to use an immunological test with T-SPOT to detect tuberculosis when the number of CD4 lymphocytes decreases to less than 200 cells/ml.
About the Authors
V. S. BorovitskyRussian Federation
Borovitsky Vladislav Semenovich
Moscow
M. V. Sinitsyn
Russian Federation
Moscow
M. V. Gorbunova
Russian Federation
Moscow
S. L. Babak
Russian Federation
Moscow
References
1. World Health Organization. Global tuberculosis report 2015. 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf. Accessed 29 Nov 2015.
2. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. Licence: CC BY-NC-SA 3.0 IGO. Режим доступа: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf 25.11.2024.
3. Global tuberculosis report 2021. Geneva: World Health Organization. 2021. 57 p.
4. Yu L., Mo P., Wei Z., Fu R., Yang M., Ji B. et al. Development and evaluation of a new interferon-gamma release assay for the diagnosis of tuberculosis infection in HIV-infected individuals in China // Infect. Dis. (Lond.). 2015. Vol. 47. Р. 237–243. doi: 10.3109/00365548.2014.988749.
5. Grabovskaya M.S., Motanova L.N., Kudlai D.A., Doctorova N.P. Possibilities of a skin test with recombinant tuberculosis allergen as a predictor of tuberculosis development in HIV-infected patients with different immune status. Bulletin of the Central Research Institute of Tuberculosis, 2024, Vol. 8, No. 3, рр. 42–51 (In Russ.)]. https://doi.org/10.57014/2587-6678-2024-8-3-42-51.
6. World Health Organization. Systematic screening for active tuberculosis: an operational guide. 2015. http://apps.who.int/iris/bitstream/10665/181164/1/9789241549172_eng.pdf. Accessed 29 Nov 2015.
7. Cai R., Chen J., Guan L., Sun M., Sun Y., Shen Y. et al. Relationship between T-SPOT.TB responses and numbers of circulating CD4+ T-cells in HIV infected patients with active tuberculosis // Biosci Trends. 2014. Vol. 8. Р. 163–168. doi: 10.5582/bst.2014.01032.
8. Whitworth H.S., Scott M., Connell D.W., Dongés B., Lalvani A. IGRAs — the gateway to T cell based TB diagnosis // Methods. 2013. Vol. 61. Р. 52–62. doi: 10.1016/j.ymeth.2012.12.012.
9. Hamada Y., Cirillo D. M., Matteelli A., Penn-Nicholson A., Rangaka M. X., Ruhwald M. Tests for tuberculosis infection: landscape analysis // Eur. Respir. J. 2021. Nov 25. Vol. 58, No. 5. Р. 2100167. doi: 10.1183/13993003.00167-2021.
10. Lang T.A., Sesik M. How to describe statistics in medicine. Annotated guide for authors, editors, and reviewers / trans. from English edited by V. P. Leonov. Moscow: Publishing house Practical Medicine, 2011. 480 p. (In Russ.)
11. Petri A., Sabin K. Visual medical statistics / translated from English under the editorship of V. P. Leonov. 2nd ed., revised and enlarged. Moscow: Publishing house GEOTAR-Media, 2009. 168 p. (In Russ.)
12. Huo Zhen-yu, Peng Li. Accuracy of the interferon-g release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis // BMC Infect Dis. 2016. Vol. 16. Р. 350. Published online 2016 Jul 22. doi: 10.1186/s12879-016-1687-8.
13. Leidl L., Mayanja-Kizza H., Sotgiu G., Baseke J., Ernst M., Hirsch C. et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection // Eur. Respir. J. 2010. Vol. 35. Р. 619–626. doi: 10.1183/09031936.00045509.
14. Markova R., Todorova Y., Drenska R., Elenkov I., Yankova M., Stefanova D. Usefulness of interferon-gamma release assays in the diagnosis of tuberculosis infection in HIV-Infected patients in Bulgaria // Biotechnol. Biotech. Equip. 2009. Vol. 23. Р. 1103–1108. doi: 10.1080/13102818.2009.10817622.
15. Cattamanchi A., Ssewenyana I., Davis J.L., Huang L., Worodria W., den Boon S. et al. Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection // BMC Infect Dis. 2010. Vol. 10. Р. 75. doi: 10.1186/1471-2334-10-75.
16. Tan C., Hung C., Lai C., Liao C., Chou C., Huang Y. et al. Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferongamma in HIV-infected patients // J. Acquir. Immune Defic. Syndr. 2010. Vol. 53. Р. 546–547. doi: 10.1097/QAI.0b013e3181bc467f.
17. Santin M., Muñoz L., Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis // PLoS One. 2012. Vol. 7. Р. e32482. doi: 10.1371/journal.pone.0032482.
18. Chen J., Zhang R., Wang J., Liu L., Zheng Y., Shen Y. et al. Interferon-gamma release assays for the diagnosis of active tuberculosis in HIVinfected patients: a systematic review and meta-analysis // PLoS One. 2011. Vol. 6. Р. e26827. doi: 10.1371/journal.pone.0026827.
Review
For citations:
Borovitsky V.S., Sinitsyn M.V., Gorbunova M.V., Babak S.L. Diagnostic value of recombinant tuberculosis allergen and Т-spot for the diagnosis of tuberculosis in patients with HIV infection. HIV Infection and Immunosuppressive Disorders. 2025;17(3):83-89. (In Russ.) https://doi.org/10.22328/2077-9828-2025-17-3-83-89

.png)





























